| 25th Sep 2013 7:00 am |
RNS |
Preliminary Results |
| 16th Sep 2013 7:00 am |
RNS |
European Marketing Authorisation transfer on track |
| 9th Sep 2013 7:00 am |
RNS |
Clinigen to Manage Access Program for Eisai |
| 6th Sep 2013 7:01 am |
RNS |
Notice of Results |
| 6th Sep 2013 7:00 am |
RNS |
Appointment of joint broker |
| 31st Jul 2013 7:00 am |
RNS |
Clinigen to Manage Third Access program for BTG |
| 25th Jul 2013 7:00 am |
RNS |
Pre-Close Trading Update |
| 11th Jul 2013 9:32 am |
RNS |
Appointment of Executive Director |
| 9th Jul 2013 7:00 am |
RNS |
Organizational Changes to Scale up for Growth |
| 4th Jul 2013 11:15 am |
RNS |
Holding(s) in Company |
| 20th Jun 2013 7:00 am |
RNS |
Extension of agreement with Accord Healthcare |
| 3rd May 2013 7:00 am |
RNS |
Holding(s) in Company |
| 2nd May 2013 9:58 am |
RNS |
Director/PDMR Shareholding |
| 29th Apr 2013 7:00 am |
RNS |
New £20m banking facility |
| 5th Apr 2013 7:00 am |
RNS |
Holding(s) in Company |
| 26th Mar 2013 7:20 am |
BUS |
Clinigen Group plc acquires oncology support therapy Cardioxane for US$33 million |
| 11th Mar 2013 7:00 am |
BUS |
Clinigen Group and Theravance Entered into Exclusive Commercialization Agreement in the EU for Antibacterial VIBATIV® |
| 27th Feb 2013 7:00 am |
RNS |
Interim results |
| 14th Feb 2013 3:35 pm |
RNS |
Holding(s) in Company |
| 14th Feb 2013 3:34 pm |
RNS |
Holding(s) in Company |
| 14th Feb 2013 3:32 pm |
RNS |
Holding(s) in Company |
| 31st Jan 2013 7:00 am |
RNS |
Notice of Interim Results |
| 24th Jan 2013 7:00 am |
RNS |
Annual Report and accounts |
| 21st Dec 2012 10:38 am |
RNS |
Holding(s) in Company |
| 22nd Nov 2012 10:10 am |
RNS |
Holding(s) in Company |
| 11th Oct 2012 7:00 am |
RNS |
Exercise of over-allotment option |
| 27th Sep 2012 9:20 am |
RNS |
Notification of major interest in shares |
| 26th Sep 2012 11:01 am |
RNS |
Director's Share Dealing |
| 25th Sep 2012 7:15 am |
RNS |
Stabilisation Notice |
| 25th Sep 2012 7:00 am |
RNS |
First day of dealings |
